Squamous cell carcinoma antigens and use therefor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11471740

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to tumor antigens of the squamous epithelial carcinoma, nucleic acids encoding the same as well as antibodies directed against the same. The invention furthermore relates to methods for the generation of antigen presenting cells and T cells specific for such antigens. Eventually, the invention comprises diagnostic and therapeutic methods for the detection/for the treatment of a squamous epithelial carcinoma, in particular a squamous epithelial carcinoma in the otolaryngologic, head, and neck region.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VAECGENE BIOTECH GMBHMARCHIONISTRASSE 25 MUENCHEN D-81377

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gires, Oliver Muenchen, DE 1 9
Muenz, Markus Greiling, DE 13 60
Schaffrik, Martina Muenchen, DE 1 9
Zeidler, Reinhard Olching, DE 15 123

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation